Toggle Side Panel
News + Resources
Market Trends
Downloads & Resources
CDMO News
CRO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live Europe
CDMO Live Americas
ExM Leaders
More options
Sign in
Sign up
Search for:
News + Resources
Market Trends
Downloads & Resources
CDMO News
CRO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live Europe
CDMO Live Americas
ExM Leaders
Search for:
Close search
Policy Briefings
China Aims for 25% of Global First-in-Class Drugs by 2030
White House Secures $19.6B in Pharma Manufacturing Pledges
Trump Gives Generic Drugmakers Two Years to Reshore Before Tariffs Hit
Warren, Scott revive bill to map foreign control of US drug supply
Congress Proposes Federal Oversight for US-China Drug Licensing Deals
FDA Shakeup Continues: Høeg Fired, Davis Named Acting CDER Head
Trump Confirms Makary Exit; Diamantas Named Acting Chief
Regeneron Closes MFN Deal; Offers Gene Therapy Free
US Pharma Tariffs: 100% Headline Rate, Far Lower Real-World Impact
The European Biotech Act, Explained
Multistate Lawsuit Targets CDC Childhood Vaccine Rollback
Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next
FDA and EMA Issue Joint AI Principles for Drug Development
EU Critical Medicines Act: What Manufacturing Leaders Must Prepare For
TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs?
J&J Strikes Drug Pricing Deal with Trump Administration
Nine Drugmakers Sign Trump MFN Deals in Single Day, Pledge $150B in US Manufacturing
US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds
Trump Administration Launches Review of Global Drug Pricing Practises
AstraZeneca Signs Trump’s Second MFN Drug Pricing Deal
Trump Exempts Generic Drugs from Pharmaceutical Tariffs, Boosting Indian Pharma Stocks
« Previous
Page
1
Page
2
Next »
Gaelic Laboratories Launches Dual-Source Beta-Lactam Strategy With Athlone
Andelyn Biosciences Begins Commercial Manufacturing of FDA-Approved Fayuvi
mAbxience to Develop and Manufacture Emicizumab Biosimilar for Sandoz
GBI Biomanufacturing Launches SmartScale GMP Platform for Early-Stage Biologics
Cellares Partners With GenomeFrontier to Evaluate Automated Virus-Free CAR-T Manufacturing
WuXi XDC Licenses WuXiTecan-2 ADC Technology to Ona Therapeutics
Quotient Sciences Reports Interim Results From AI-Guided Formulation Study
Kincellis Advanced Therapies Formed Through Kincell and Cellipont Merger
Charles River Laboratories Launches Rapid Cell Banking Programs to Cut Release Timelines
Upperton Gains MHRA Approval for 7,000-Sq.-Ft. Sterile Manufacturing Facility
Piramal Pharma Solutions Adds 4.3 MWp Solar Plant at UK Facility
ProBio and Kun Tuo Partner on Integrated CDMO-CRO Solutions in China
Hovione Opens 31,000-Square-Foot Facility to Double U.S. Spray Drying Capacity
Shilpa Biologicals to Develop and Manufacture PD-1 Biosimilars for MENA
Neuland Expands Peptide Manufacturing Capacity to 7,000 L
EirGenix Opens Taiwan Microbial Facility
Axiom Biosciences Partners With GeneFab on Cell and Gene Therapy Manufacturing
FAREVA Acquires Türkiye Site With Capacity of 445 Million Packs Annually
« Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next »
European CDMO Landscape 2025:
Download the latest edition